BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7752450)

  • 1. The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers.
    Inagaki Y; Yamamoto N; Chida T; Okamura N; Tanaka M
    Jpn J Antibiot; 1995 Mar; 48(3):368-79. PubMed ID: 7752450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of levofloxacin, an optically-active isomer of ofloxacin, on fecal microflora in human volunteers.
    Inagaki Y; Nakaya R; Chida T; Hashimoto S
    Jpn J Antibiot; 1992 Mar; 45(3):241-52. PubMed ID: 1512920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of DQ-2556, a new cephalosporin derivative, on fecal microflora].
    Inagaki Y; Chida T; Nakaya R; Hashimoto S
    Jpn J Antibiot; 1992 Oct; 45(10):1332-41. PubMed ID: 1479685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
    Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
    Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.
    Nakane T; Iyobe S; Sato K; Mitsuhashi S
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2822-6. PubMed ID: 8593031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro activities of DU-6859a and other fluoroquinolones against Japanese isolates of anaerobic bacteria.
    Kato N; Kato H; Tanaka-Bando K; Watanabe K; Ueno K
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S31-5. PubMed ID: 8953104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecological effect of gatifloxacin on the normal human intestinal microflora.
    Edlund C; Nord CE
    J Chemother; 1999 Feb; 11(1):50-3. PubMed ID: 10078781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
    Morrissey I; Smith JT
    J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of DU-6859a against anaerobic bacteria.
    Wexler HM; Molitoris E; Reeves D; Finegold SM
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2504-9. PubMed ID: 7840599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.
    van Nispen CH; Hoepelman AI; Rozenberg-Arska M; Verhoef J; Purkins L; Willavize SA
    Am J Surg; 1998 Dec; 176(6A Suppl):27S-31S. PubMed ID: 9935254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sparfloxacin on fecal microflora and its fecal concentration in patients with bacillary dysentery].
    Sagara H; Tsunoda T; Nitta Y
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1136-43. PubMed ID: 1662252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.
    Niki Y; Itokawa K; Okazaki O
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1751-5. PubMed ID: 9661016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli.
    Tomayko JF; Korten V; Murray BE
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):45-7. PubMed ID: 7867298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of azithromycin on fecal flora of healthy adult volunteers].
    Uchino U; Kanayama A; Hasegawa M; Kobayashi I; Muto H; Enogaki K; Matsunaga T; Ogawa M; Cyong JC; Kodama K
    Jpn J Antibiot; 1995 Sep; 48(9):1119-30. PubMed ID: 7474332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of a new fluoroquinolone, marbofloxacin (RO 09-1168) against strictly anaerobic bacteria and some bacteria from human fecal flora].
    Dubreuil L; Houcke I; Leroy I
    Pathol Biol (Paris); 1996 May; 44(5):333-6. PubMed ID: 8758470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates.
    Jones RN; Johnson DM; Biedenbach DJ; Marshall SA
    Diagn Microbiol Infect Dis; 1995 Nov; 23(3):123-7. PubMed ID: 8849658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fluoroquinolones on the gastrointestinal flora.
    Murray BE
    Rev Infect Dis; 1989; 11 Suppl 5():S1372-8. PubMed ID: 2672259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of rokitamycin on bacterial flora in human feces].
    Motohiro T; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S
    Jpn J Antibiot; 1990 Feb; 43(2):285-317. PubMed ID: 2362352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of cefodizime via intravenous bolus injection on human fecal flora].
    Motohiro T; Yoshinaga Y; Sasaki H; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S
    Jpn J Antibiot; 1990 Jul; 43(7):1183-213. PubMed ID: 2232150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
    Leigh DA; Harris C; Tait S; Walsh B; Hancock P
    J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.